07:00 , May 11, 1998 |  BC Week In Review  |  Company News

Response Biomedical, BioCare Corp. deal

The companies signed a letter of intent to develop in Taiwan, China and other Asian territories RBM's RAMP (Rapid Analyte Measurement Platform) assays to identify immunologically active substances. BioCare, which will make an equity investment...